Acetone Market Declined by Around 2% in Oct 2017
Market Review: The Chinese phenol market continued the uptrend this week. Negotiation prices moved up. Up to December 7, the reference negotiation prices for phenol in East China were in the range of RMB 10,200-10,400/mt, up RMB 750/mt week on week. The average price was RMB 10,000/mt, up 6.72% week on week. The benzene prices fluctuated at high levels, but phenol market saw no pressure. Supply and demand were the major influencing factors. The supply was tight in the market, and holders controlled the sales. Phenol producers raised prices again to RMB 10,000/mt. The BPA market followed the uptrend. The profits were fine. Players were cautious and optimistic.
Forecast: The tight supply is the major reason for the firm phenol market. Some imported goods will arrive. But some phenolic ketone units in China will undergo maintenance in the future. Producers will see no sales pressure. It is predicted that the Chinese phenol market will inch up next week.
Looking for chemical products? Let suppliers reach out to you!
2026-06-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Recommend Reading
-
2025 Review of Acrylonitrile Industry Events in China
-
Geopolitical Risks in the Middle East Escalate: An Analysis of the Impact on the Acrylic Market
-
Escalation of Middle East Conflict Drives Significant Increase in China's Gasoline and Diesel Prices
-
On March 3rd, the market price of pure benzene in China continued to rise
-
After 5 consecutive months of price increases exceeding 60%, the current round of butadiene rubber price hikes in China may come to an end
-
Stahl Launches Ultra-Functional Carbodiimide Crosslinker for High-Performance Coatings
-
Wacker Opens Biotechnology Center in Munich
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
Global Chemical Exports Are Freezing in 2026
-
The Most Striking Thing in BASF’s 2025 Results Isn’t Profit — It’s “Cutting Weight” and “Stopping the Bleeding” at the Same Time